South Carolina Court Heard Opioid Insurance Case
The state supreme court will decide if insurance covers liability linked to more than 350 opioid lawsuits.
Updated on Oct. 14, 2026 in Substance Abuse
Live Poll
Should insurance companies be required to cover legal costs for drug companies facing opioid-related lawsuits?
The South Carolina Supreme Court has agreed to determine whether insurance policies must cover costs associated with opioid-related litigation. This decision could impact how companies, including JM Smith Corp., manage financial liability for opioid-related claims.
Why it matters
The court's ruling will clarify if the policy language 'because of bodily injury' obligates insurers to cover damages in large-scale opioid litigation. This interpretation could significantly influence future legal strategies and financial stability for businesses involved in the epidemic.
A U.S. District Court certified a question regarding insurance policy interpretations after JM Smith Corp. faced 350 lawsuits. The court must decide if the specific phrase because of bodily injury limits coverage, a question currently being weighed by high courts in Florida and Georgia.
The players
JM Smith Corp.
A company currently facing more than 350 opioid-related lawsuits.
Judge Jacquelyn D. Austin
A U.S. District Court judge who certified the legal question to the state high court.
The details
The dispute centers on the contractual definition of bodily injury and whether it applies to mass-tort litigation involving opioid distribution. Judge Jacquelyn D. Austin certified the question to determine if coverage is triggered by the systemic nature of these claims or restricted to direct individual physical harm. The outcome will set a legal standard for how liability insurance responds to complex, multi-party public health litigation.
Timeline
October 13, 2026: Judge Jacquelyn D. Austin issued the certification order to the state supreme court.
Health Landscape
This case follows the pattern set by the ongoing multistate opioid litigation settlements by addressing how corporate liability is financed. It highlights an emerging shift in how courts interpret insurance contracts within the complex framework of the national opioid epidemic.
This legal outcome may influence the availability of resources for addiction treatment and public health programs by determining corporate funding capabilities. Residents should discuss the impact of local opioid-related policy changes with their physician or local health department representatives.
The takeaway
This case highlights the intersection of insurance law and public health responsibility in the wake of the opioid crisis. Residents should monitor how legal shifts affect funding for local prevention and recovery services.
Further reading
For broader context on how opioid policy impacts our state, explore Substance Abuse.
Source note: This article includes information reported by Bloomberglaw.
Live Poll
Should insurance companies be required to cover legal costs for drug companies facing opioid-related lawsuits?
